Objective: Among priorities in neurology is the development of a preclinical diagnosis of Parkinson’s dis- ease (PD) by searching for peripheral markers, mostly in body fluids, in patients at an early clinical stage, although there is no evidence that they are also characteristic of preclinical stage.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Parkinsonism & Related Disorders
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2017 Published by Elsevier Inc.